Recorded November 30, 2022
Webcast / Podcast Description:
Treating CLL/SLL is a little like a chess game, as one needs to always be thinking a few moves ahead. Most treatments for CLL/SLL are not curative, and when relapse occurs it is important to have a plan in place with some options that can knock back the disease again.
Join CLL/SLL expert Dr. Susan O’Brien, and 22-year CLL survivor Terry Evans, for this fast-paced podcast / webcast as they dive deeper into this topic with five questions in roughly 15 minutes. Questions cover starting treatment, treatment options, determining your healthcare team, and how to better participate in shared decision-making.
This webcast / podcast is an additional resource built upon the webinar on this topic, found here. Increasing your knowledge and having a plan in place for your future treatment moves is part of you advocating for your best possible care. CLL Society believes Smart Patients Get Smart Care™.
Susan O’Brien, MD
Professor of Medicine
University of California, Irvine
22-year CLL Patient and Advocate
Director, CLL Society Support Network
CLL Society has partnered with the National Association for Continuing Education (NACE) for the production of these educational resources.
This program is made possible by support from BeiGene, Bristol Myers Squibb, Lilly Oncology, Genentech, and Janssen.
Supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.